SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
OPKO HEALTH INC
(NYSE:OPK Last Sale: 2.36 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NYSE: (OPK : $2.36)
$1,580,795 million Market Cap at Market Close, July 1, 2022
Employs 17.
Biomedics SubIndustry up .00% / Health Industry up .00% Today

4400 Biscayne Blvd Research Report Earnings Snapshot - Last 11/07/18
Miami, TX 33137 Fact Sheet
Phone: (305) 575-4138 Financial Statements
Peer Comparison
Annual Reports

Phillip Frost, Chmn./CEO, Juan Rodriguez, CFO
Focus is blood tests for Alzheimer's and certain cancers. Formerly EXEGENICS INC of Dallas until June 2007 and CYTOCLONAL PHARMACEUTICS INC (NASDAQ:CYPH) until June 2001. Transfer to Pink Sheets October 13, 2004. Closely-held by Frost, with 39%.
Historical Charts    Technical Analysis
No Historical Data available for OPK

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common OPK $2.36 $2.36 0 .0 $2.09 $2.36 10,751,136 $2.09 $2.36 669,828,524
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock #############

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
14-JUN-07 EXEG Symbol Changed to OPK
23-OCT-01 CYPH Symbol Changed to EXEG

A2
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex